Government to support new drug discovery for schizophrenia.

Published: 2005-11-30 06:59:00

Updated: 2005-11-30 06:59:00

The MOHW plans to develope AAD-200, a new candidate compount for the treatment of Alzheimer, schizophrenia and Parkinsonian disorders, which was discovered as a frontier project of the brain research in Korea.

The MOHW is going to spend about 20 billion won for 3 years (60% by the government a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK